Cargando…

Trends in resistant Enterobacteriaceae and Acinetobacter species in hospitalized patients in the United States: 2013–2017

BACKGROUND: Trends in antimicrobial resistance help inform infection control efforts. We examined trends in resistance for Enterobacteriaceae and Acinetobacter spp. from 2013 to 2017 in hospitalized US patients. METHODS: We analyzed antimicrobial susceptibility of non-duplicate isolates in hospitali...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Vikas, Ye, Gang, Olesky, Melanie, Lawrence, Kenneth, Murray, John, Yu, Kalvin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708167/
https://www.ncbi.nlm.nih.gov/pubmed/31443635
http://dx.doi.org/10.1186/s12879-019-4387-3
_version_ 1783445965551697920
author Gupta, Vikas
Ye, Gang
Olesky, Melanie
Lawrence, Kenneth
Murray, John
Yu, Kalvin
author_facet Gupta, Vikas
Ye, Gang
Olesky, Melanie
Lawrence, Kenneth
Murray, John
Yu, Kalvin
author_sort Gupta, Vikas
collection PubMed
description BACKGROUND: Trends in antimicrobial resistance help inform infection control efforts. We examined trends in resistance for Enterobacteriaceae and Acinetobacter spp. from 2013 to 2017 in hospitalized US patients. METHODS: We analyzed antimicrobial susceptibility of non-duplicate isolates in hospitalized patients (not limited to hospital-acquired infections) in the US BD Insights Research Database. Resistance profiles of interest were extended-spectrum beta-lactamase (ESBL)-producing, multidrug resistant (MDR), and carbapenem-nonsusceptible (Carb-NS) phenotypes of Enterobacteriaceae, and MDR and Carb-NS Acinetobacter spp. Time series models were used to evaluate the patterns of resistance trends in rate per 100 hospital admissions and proportion per isolates tested. RESULTS: More than 1 million Enterobacteriaceae isolates were obtained from 411 hospitals; 12.05% were ESBL, 1.21% Carb-NS, and 7.08% MDR. Urine was the most common source. For Acinetobacter spp. (n = 19,325), 37.48% were Carb-NS, 47.66% were MDR, and the most common source was skin/wound cultures. Trend analyses showed that the rates of ESBL and Carb-NS Enterobacteriaceae per 100 hospital admissions increased significantly between 2013 and 2017. Rates of MDR Enterobacteriaceae and Carb-NS and MDR Acinetobacter spp. decreased during this time period. Trends in proportions of resistant isolates generally mirrored trends in rates per 100 hospital admissions. MDR Enterobacteriaceae and Carb-NS and MDR Acinetobacter spp. were more common in winter than summer. CONCLUSIONS: In this large-scale study of patients in US hospitals, rates of ESBL and Carb-NS Enterobacteriaceae per 100 hospital admissions increased between 2013 and 2017. MDR Enterobacteriaceae and MDR and Carb-NS Acinetobacter spp. isolates decreased over this period. These data support continuing infection control and stewardship efforts and the development of new therapeutic options. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12879-019-4387-3) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6708167
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-67081672019-08-28 Trends in resistant Enterobacteriaceae and Acinetobacter species in hospitalized patients in the United States: 2013–2017 Gupta, Vikas Ye, Gang Olesky, Melanie Lawrence, Kenneth Murray, John Yu, Kalvin BMC Infect Dis Research Article BACKGROUND: Trends in antimicrobial resistance help inform infection control efforts. We examined trends in resistance for Enterobacteriaceae and Acinetobacter spp. from 2013 to 2017 in hospitalized US patients. METHODS: We analyzed antimicrobial susceptibility of non-duplicate isolates in hospitalized patients (not limited to hospital-acquired infections) in the US BD Insights Research Database. Resistance profiles of interest were extended-spectrum beta-lactamase (ESBL)-producing, multidrug resistant (MDR), and carbapenem-nonsusceptible (Carb-NS) phenotypes of Enterobacteriaceae, and MDR and Carb-NS Acinetobacter spp. Time series models were used to evaluate the patterns of resistance trends in rate per 100 hospital admissions and proportion per isolates tested. RESULTS: More than 1 million Enterobacteriaceae isolates were obtained from 411 hospitals; 12.05% were ESBL, 1.21% Carb-NS, and 7.08% MDR. Urine was the most common source. For Acinetobacter spp. (n = 19,325), 37.48% were Carb-NS, 47.66% were MDR, and the most common source was skin/wound cultures. Trend analyses showed that the rates of ESBL and Carb-NS Enterobacteriaceae per 100 hospital admissions increased significantly between 2013 and 2017. Rates of MDR Enterobacteriaceae and Carb-NS and MDR Acinetobacter spp. decreased during this time period. Trends in proportions of resistant isolates generally mirrored trends in rates per 100 hospital admissions. MDR Enterobacteriaceae and Carb-NS and MDR Acinetobacter spp. were more common in winter than summer. CONCLUSIONS: In this large-scale study of patients in US hospitals, rates of ESBL and Carb-NS Enterobacteriaceae per 100 hospital admissions increased between 2013 and 2017. MDR Enterobacteriaceae and MDR and Carb-NS Acinetobacter spp. isolates decreased over this period. These data support continuing infection control and stewardship efforts and the development of new therapeutic options. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12879-019-4387-3) contains supplementary material, which is available to authorized users. BioMed Central 2019-08-23 /pmc/articles/PMC6708167/ /pubmed/31443635 http://dx.doi.org/10.1186/s12879-019-4387-3 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Gupta, Vikas
Ye, Gang
Olesky, Melanie
Lawrence, Kenneth
Murray, John
Yu, Kalvin
Trends in resistant Enterobacteriaceae and Acinetobacter species in hospitalized patients in the United States: 2013–2017
title Trends in resistant Enterobacteriaceae and Acinetobacter species in hospitalized patients in the United States: 2013–2017
title_full Trends in resistant Enterobacteriaceae and Acinetobacter species in hospitalized patients in the United States: 2013–2017
title_fullStr Trends in resistant Enterobacteriaceae and Acinetobacter species in hospitalized patients in the United States: 2013–2017
title_full_unstemmed Trends in resistant Enterobacteriaceae and Acinetobacter species in hospitalized patients in the United States: 2013–2017
title_short Trends in resistant Enterobacteriaceae and Acinetobacter species in hospitalized patients in the United States: 2013–2017
title_sort trends in resistant enterobacteriaceae and acinetobacter species in hospitalized patients in the united states: 2013–2017
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708167/
https://www.ncbi.nlm.nih.gov/pubmed/31443635
http://dx.doi.org/10.1186/s12879-019-4387-3
work_keys_str_mv AT guptavikas trendsinresistantenterobacteriaceaeandacinetobacterspeciesinhospitalizedpatientsintheunitedstates20132017
AT yegang trendsinresistantenterobacteriaceaeandacinetobacterspeciesinhospitalizedpatientsintheunitedstates20132017
AT oleskymelanie trendsinresistantenterobacteriaceaeandacinetobacterspeciesinhospitalizedpatientsintheunitedstates20132017
AT lawrencekenneth trendsinresistantenterobacteriaceaeandacinetobacterspeciesinhospitalizedpatientsintheunitedstates20132017
AT murrayjohn trendsinresistantenterobacteriaceaeandacinetobacterspeciesinhospitalizedpatientsintheunitedstates20132017
AT yukalvin trendsinresistantenterobacteriaceaeandacinetobacterspeciesinhospitalizedpatientsintheunitedstates20132017